Offer - Urjas Oil for just ₹ 1 X
Mimcipar, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Hyperparathyroidism. Mimcipar also has some secondary and off-label uses. These are listed below.
The right dosage of Mimcipar depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Mimcipar as well, which are listed below. Normally, these side effects of Mimcipar are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Mimcipar is Unknown for pregnant women and Unknown for women who are breastfeeding. Further, the section on Mimcipar related warnings talks about Mimcipar's effects on the liver, heart and kidney.
Some other conditions that can be affected by Mimcipar are listed in the contraindications section below.
Additionally, Mimcipar may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Mimcipar is considered safe while driving, and is addictive.
Mimcipar is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Mimcipar safe for pregnant women?
It is not known what effect Mimcipar will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Mimcipar safe during breastfeeding?
There is no research available on the side effects of Mimcipar in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Mimcipar on the Kidneys?
Mimcipar may have mild side effects on the kidneys.
What is the effect of Mimcipar on the Liver?
Mimcipar can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Mimcipar on the Heart?
The heart can be affected by Mimcipar. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Mimcipar should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Mimcipar unless your doctor advises you to do so -
Is this Mimcipar habit forming or addictive?
Mimcipar is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Mimcipar since it will not make you feel sleepy.
Is it safe?
Yes, but take Mimcipar only as per medical advice.
Is it able to treat mental disorders?
No, the use of Mimcipar in mental disorders is not effective.
Interaction between Food and Mimcipar
Taking Mimcipar with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Mimcipar
No research has been done on this till date. Therefore, it is not known what the effect of taking Mimcipar with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sensipar® (cinacalcet)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 338-339
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 320-321